CareDx: Q4 Earnings Snapshot

In this article:

BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Wednesday reported a loss of $118.1 million in its fourth quarter.

On a per-share basis, the Brisbane, California-based company said it had a loss of $2.21. Losses, adjusted for non-recurring costs and stock option expense, were 17 cents per share.

The molecular diagnostics company posted revenue of $65.6 million in the period.

For the year, the company reported that its loss widened to $190.3 million, or $3.54 per share. Revenue was reported as $280.3 million.

CareDx expects full-year revenue in the range of $260 million to $274 million.

CareDx shares have fallen 19% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $9.72, a drop of 42% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA

Advertisement